Why the study?
Cisplatin is widely used in adults and children, but causes toxicities that may be reduced by the potential chemoprotectant N-acetylcysteine.
Does N-acetylcysteine reduce cisplatin toxicity in adults and children receiving cisplatin treatment?
Comparison
N-acetylcysteine administration after cisplatin vs cisplatin alone
Design
Literature review
Authors
Loading...
Late NAC may reduce cisplatin toxicities without compromising efficacy; leaves open clinical translation.
Does N-acetylcysteine reduce cisplatin toxicity in adults and children receiving cisplatin treatment?
N-acetylcysteine represents a potential chemoprotective agent to decrease toxicities secondary to cisplatin treatment without compromising its antitumor efficacy.
Zavala-Valencia et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: